Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Finasteride-loaded nanoparticles may help treat alopecia.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Gut health may influence Alopecia Areata, suggesting new treatments.

People with alopecia areata often have lower vitamin D levels and are more likely to be deficient in it.

Epigenetic changes in blood cells may contribute to alopecia areata.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Glucocorticoid use in dogs quickly causes liver changes and Cushing's syndrome symptoms.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

New alopecia treatments aim for better results and fewer side effects.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Diphencyprone therapy for hair loss can cause vitiligo.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Combining 5% minoxidil and 0.5% anthralin can help regrow hair in some severe alopecia areata patients.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.